Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Evoke Pharma (EVOK) Inventory (2020 - 2025)

Historic Inventory for Evoke Pharma (EVOK) over the last 6 years, with Q3 2025 value amounting to $599908.0.

  • Evoke Pharma's Inventory rose 2158.46% to $599908.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $599908.0, marking a year-over-year increase of 2158.46%. This contributed to the annual value of $445081.0 for FY2024, which is 762.89% down from last year.
  • Latest data reveals that Evoke Pharma reported Inventory of $599908.0 as of Q3 2025, which was up 2158.46% from $641872.0 recorded in Q2 2025.
  • Evoke Pharma's Inventory's 5-year high stood at $641872.0 during Q2 2025, with a 5-year trough of $185534.0 in Q4 2021.
  • Moreover, its 5-year median value for Inventory was $445081.0 (2024), whereas its average is $402575.1.
  • Examining YoY changes over the last 5 years, Evoke Pharma's Inventory showed a top increase of 16143.94% in 2021 and a maximum decrease of 2154.35% in 2021.
  • Quarter analysis of 5 years shows Evoke Pharma's Inventory stood at $185534.0 in 2021, then soared by 55.97% to $289378.0 in 2022, then skyrocketed by 66.51% to $481840.0 in 2023, then dropped by 7.63% to $445081.0 in 2024, then skyrocketed by 34.79% to $599908.0 in 2025.
  • Its last three reported values are $599908.0 in Q3 2025, $641872.0 for Q2 2025, and $532145.0 during Q1 2025.